MGFA has partnered with Bionews to feature the Myasthenia Gravis News feed on our website, providing the community with research updates, disease management insights, and relevant news. All content is original and produced by Bionews’ editorial staff, and perspectives from patients and caregivers. Information is not meant to replace or provide medical advice.
Myasthenia Gravis News – The Web’s Daily Resource for Myasthenia Gravis News
- Real-world data show gMG treatment works across patient groups
by Andrea Lobo on September 10, 2026 at 2:30 pmVyvgart (efgartigimod alfa) is generally well tolerated and effective for adults with generalized myasthenia gravis (gMG), regardless of the presence and type of disease-causing antibody, according to a real-world study in Japan. The treatment, which has been approved in Japan for gMG regardless of antibody status since 2022 and expanded for that indication in the U.S. this The post Real-world data show gMG treatment works across patient groups appeared first on Myasthenia Gravis News.
- Myasthenia gravis is more than the list of its symptoms
by Sarah Bendiff on September 10, 2026 at 2:00 pmI blame a whole lot of things on myasthenia gravis (MG), even things that are not actually considered symptoms. My body says otherwise, however. Although I still believe some of the issues I experience might belong to a secret illness that has not been discovered yet, certain feelings and physical experiences keep pointing back to The post Myasthenia gravis is more than the list of its symptoms appeared first on Myasthenia Gravis News.
- gMG patients can safely use self-injectors for experimental therapy
by Andrea Lobo on September 9, 2026 at 5:15 pmA prefilled syringe and an autoinjector used to deliver gefurulimab, an experimental therapy in late-stage development for generalized myasthenia gravis (gMG), can be safely and effectively used by most gMG patients, caregivers, and healthcare professionals. That’s according to a simulated-use study, which aims to assess if people can safely and effectively use a medical product, The post gMG patients can safely use self-injectors for experimental therapy appeared first on Myasthenia Gravis News.
- Treatment satisfaction may not alter adherence in MG, study suggests
by Marisa Horak, MS on September 8, 2026 at 12:00 pmSatisfaction with treatment doesn’t necessarily affect whether people with myasthenia gravis (MG) take their medications as directed, according to a new study that surveyed nearly 100 patients at a center in China. Findings also indicate that people living with MG who are older are less likely to take their medications as directed, and that patients who have had The post Treatment satisfaction may not alter adherence in MG, study suggests appeared first on Myasthenia Gravis News.
- When I could no longer be a summer person, fall made room for me
by Shawna Barnes on September 7, 2026 at 2:00 pmI used to love summer. I wasn’t just a “summer person” — I lived in it. I was an outdoor lifeguard and swim instructor, spending entire days in the sun, water, and heat without thinking twice. My body used to thrive there. Until it didn’t. Myasthenia gravis (MG) arrived, and summer became something I watched The post When I could no longer be a summer person, fall made room for me appeared first on Myasthenia Gravis News.
** MGFA Disclaimer – Please read
Myasthenia Gravis Foundation of America (MGFA) and Bionews, Inc. (specifically Myasthenia Gravis News) have entered into a limited agreement that allows for the MGFA to post a link to Myasthenia Gravis News on the myasthenia.org website. Myasthenia Gravis News is a digital platform intended to provide the myasthenia gravis (MG) community with the most recent news and information on MG, as well as first-hand community perspectives from patient and caregiver columnists. All articles on Myasthenia Gravis News are original content produced by in-house writers and editors. Occasionally, Bionews seeks the opinion of outside experts for interviews and Q&As.
The publishing team at Myasthenia Gravis News is made up of science writers and editors, most of whom have PhDs in the life sciences; veteran journalists; and columnists who are members of the MG community. Together, they attempt to ensure that all content published on Myasthenia Gravis News is relevant, accurate, informative, relatable, and easy to understand.
Each piece of content is carefully selected and written by Bionews writers with the MG community in mind. Sources for news stories and resource pages include peer-reviewed studies, press releases, announcements, interviews, webinars, and conference sessions, among others. All articles go through a stringent fact-checking and editing procedure as part of Bionews’ process to ensure they are accurate, objective, comprehensive, and well-explained.
Columns are written by MG patients and caregivers who provide an intimate look at what it’s like to live with the disease. While columns are largely opinion and perspective pieces, each one still goes through a comprehensive editing and fact-checking process by Bionews editors to ensure clarity, accuracy, and fairness.
Myasthenia Gravis News’ site is strictly a news and information website about the disease. It DOES NOT provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a licensed physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The information provided is for educational purposes only and does not substitute for professional medical advice.
The content reflects the unique experiences of the authors and is not necessarily the opinion, views, or recommendations of the MGFA. Medical advisors and clinicians associated with or partnering with the MGFA do not peer review articles and information posted on the Myasthenia Gravis News platform or website. MGFA should not be liable for any information, opinions, articles, advice, guidance, or details posted on the Myasthenia Gravis News site. MGFA has posted this platform as a service to the MG community. Please consult with your doctor and healthcare professionals for specific recommendations and advice pertaining to your healthcare/treatment.
